Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometrial Neoplasms | 3 | 2016 | 1351 | 0.190 |
Why?
|
Phthalazines | 1 | 2020 | 361 | 0.150 |
Why?
|
Ovarian Neoplasms | 5 | 2020 | 4823 | 0.150 |
Why?
|
Genes, BRCA2 | 1 | 2020 | 617 | 0.140 |
Why?
|
Genes, BRCA1 | 1 | 2020 | 780 | 0.140 |
Why?
|
Lymph Nodes | 2 | 2016 | 3465 | 0.120 |
Why?
|
Carcinoma, Endometrioid | 1 | 2016 | 271 | 0.110 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1786 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2015 | 2011 | 0.090 |
Why?
|
Water Movements | 1 | 2009 | 17 | 0.090 |
Why?
|
Genital Neoplasms, Female | 1 | 2015 | 516 | 0.090 |
Why?
|
Piperazines | 1 | 2020 | 2488 | 0.090 |
Why?
|
Water Microbiology | 1 | 2009 | 117 | 0.080 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2013 | 484 | 0.080 |
Why?
|
Lymphatic Metastasis | 1 | 2016 | 2906 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9185 | 0.070 |
Why?
|
Camptothecin | 1 | 2008 | 572 | 0.060 |
Why?
|
Ovary | 1 | 2009 | 981 | 0.060 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2008 | 623 | 0.060 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2009 | 484 | 0.060 |
Why?
|
CA-125 Antigen | 2 | 2016 | 279 | 0.050 |
Why?
|
Republic of Korea | 2 | 2016 | 538 | 0.050 |
Why?
|
Pelvis | 2 | 2016 | 730 | 0.050 |
Why?
|
Models, Statistical | 2 | 2013 | 5100 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11472 | 0.050 |
Why?
|
Lymph Node Excision | 2 | 2016 | 1248 | 0.050 |
Why?
|
Platinum Compounds | 1 | 2020 | 96 | 0.040 |
Why?
|
Models, Biological | 2 | 2012 | 9581 | 0.040 |
Why?
|
Gynecologic Surgical Procedures | 2 | 2013 | 336 | 0.040 |
Why?
|
Preoperative Period | 1 | 2016 | 546 | 0.030 |
Why?
|
Uterus | 1 | 2016 | 710 | 0.030 |
Why?
|
Oligohymenophorea | 1 | 2009 | 1 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2013 | 939 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2016 | 11001 | 0.020 |
Why?
|
Oceans and Seas | 1 | 2009 | 50 | 0.020 |
Why?
|
Hysterectomy | 1 | 2016 | 927 | 0.020 |
Why?
|
Middle Aged | 8 | 2020 | 213127 | 0.020 |
Why?
|
Adult | 8 | 2020 | 213712 | 0.020 |
Why?
|
Korea | 1 | 2009 | 99 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 57683 | 0.020 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2008 | 65 | 0.020 |
Why?
|
Female | 10 | 2020 | 379592 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2009 | 431 | 0.020 |
Why?
|
Aged | 5 | 2020 | 162944 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2008 | 408 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13655 | 0.020 |
Why?
|
Young Adult | 3 | 2016 | 56350 | 0.010 |
Why?
|
Prognosis | 2 | 2016 | 29010 | 0.010 |
Why?
|
Humans | 10 | 2020 | 742088 | 0.010 |
Why?
|
Cohort Studies | 2 | 2016 | 40450 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14720 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9679 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2009 | 3471 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4929 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2016 | 77098 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10248 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2009 | 6891 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13403 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2009 | 3584 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 8621 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 3800 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7873 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6259 | 0.010 |
Why?
|
Computer Simulation | 1 | 2009 | 6191 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2013 | 19862 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2008 | 5163 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 53187 | 0.010 |
Why?
|
Risk Assessment | 1 | 2012 | 23320 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20086 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 35342 | 0.010 |
Why?
|
Algorithms | 1 | 2009 | 13853 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 72145 | 0.010 |
Why?
|
Time Factors | 1 | 2009 | 40054 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2009 | 39004 | 0.000 |
Why?
|
Child, Preschool | 1 | 2009 | 40955 | 0.000 |
Why?
|
Child | 1 | 2009 | 77478 | 0.000 |
Why?
|
Adolescent | 1 | 2009 | 85649 | 0.000 |
Why?
|
Animals | 1 | 2009 | 168561 | 0.000 |
Why?
|
Concepts
(78)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_